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Introduction 
Patau Syndrome is a fatal autosomal trisomy ,usually 
seen because of Meiotic nondisjunction due to 
maternal advanced age. It is observed at a higher 
frequency in non-consanguineous union.  1 
Trisomy 13 has a prevalence of 1:12,000–1: 29,000 in 
newborns.1,2 Also known as Patau Syndrome, it is a 
rare and lethal autosomal trisomy 13 with a 
survivability of only 7-10 days.3 Only an estimated 9% 
to 14% of live births survive beyond year 1 of life and 
are associated with mosaicism.4,5 Severity of associated 
malformations also plays a key role in prognosis and 
survival.6  It presents with a wide array of dysmorphic 
features including microphthalmia, cutis aplasia, 
polydactyly, cleft lip, cleft palate, various congenital 
heart disease, omphalocele, holoprosencephaly and 
urogenital abnormalities.7,8 
There is an intense discussion as to whether timely 
NICU interventions do play a role in improving 
mortality in the neonate and long term better 
prognosis and survivability as a result , especially in 
VLBW(Very Low Birth Weight) infants.9-12 There is a 
higher reporting frequency of Trisomy’s in non-
consanguineous marriages one example of which is 
Down Syndrome.13 Currently diagnosis is based on 
increasing maternal age, sonographic findings, serum 
markers and amniocentesis followed in many cases by 
pregnancy termination as in the West.14 Risk increases 
with increasing maternal age with an average of age of 
31 years.15 
 
Case Report 
A 3 days old girl, weighing 3.2  kilograms, was born at 
term, via C-section ,to a 38 years old mother with a 
prior history of hypertension, product of a First degree 
consanguineous marriage, with a birth history of 
delayed cry, 2 cm Omphalocele, cleft lip, cleft palate, 
polydactyly-extra digit attached to the little finger in 
the right extremity and rocker bottom feet(fig.1-3). 
Patient immediately started de-sating in the low (Sa02) 
80s%, became cyanotic, where she was then shifted to 
the NICU and intubated. Mother denied any drug use 
or supplements during the pregnancy other than the 
prescribed antihypertensives.  
On examination the patient was tachypneic, had  
tachycardia, cyanosis and was  afebrile. Wide open 
bulging Anterior Fontanelle, Bilateral intercostal 
retractions, grunting and extra heart sounds were 
appreciated. Initial Lab testing revealed a pH of 7.202, 
pCO2 of 42.7 mmHg, pO2 of 55 mmHg,Hematocrit 
55%,Hb 16.5 g/dl, with a TLC of 30.5 cells/ cumm, 
Platelet count of 373x10^9 per liter (L),Sao2% of 
96%,Urea of 21 mmol/L . She was hyponatremic (128 
mEq/L), borderline hypokalemic (3.2 mEq/L).  
In a couple of days despite intense efforts to 
resuscitate and maintain the patient in the NICU, 
condition further decorated with hypokalemia of 2.61 
mEq/L, HCO3 11.3 mEq/L, HB 11.5 mg/dl, 
Thrombocytopenia 56x10^9 per liter (L) and a 
dropping hematocrit of 33%. 
Child was received from the nursery, intubated and 
started on Ambo bagging. Baby was placed on 
Ventilator overnight and extubated early morning. 
Then kept on 02 CPAP. During the course of the day at 
11.00 am, severe respiratory distress set in with 
subcostal retractions and saturation drop to 89% . 
Intubation was carried out with 3.5mm ETT-oral and 
tracheal suctioning was done. Patient was placed on 
the ventilator with PW/CPAP mode and backup 
ventilator. Post intubation vitals were around HR 160 
beats/min, RR 41 breaths/min, spO2 96% and a BSR 
of 37mg/. Later Pediatric surgical consult was called 
for to evaluate the omphalocele, which was wrapped 
with silastic silo and painted. Patient was ordered to 
be sent to the Pediatric Surgical Ward, with orders for 
chest and Abdominal X Ray.The neonate continued to 
deteriorate, became critical and died a couple of days 
later despite efforts to resuscitate.  
 
Discussion 
It is an established fact that advancing maternal age 
results in increased risk of Meiotic Non Dysfunction 
resulting in autosomal trisomies, Down's and 
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Edward's Syndrome to name a few.16 What this case 
highlights is an interesting phenomenon of reported 
trisomy in a consanguineous marriage when higher 
frequency has been reported in a non-consanguineous 
setting.13 It also brings into question the need for 
aggressive intervention to improve prognosis in terms 
of morbidity and mortality.90% of live births result in 
death in year 1 of life and median survival still stands 
at 7-10 days, and those with higher survival is 
attributed to mosaicism and severity of associated 
malformations.6 It was earlier speculated that 
adequate, timely intervention may improve 
survivability and life expectancy.17 But reports later 
also suggest the contrary and show an overall decrease 
in life expectancy.6,18,19 
 No such report has come across taking into 
consideration NICU interventions and prognosis in 
Patau Syndrome in Pakistan. From Japan a study 
revealed better prognosis with NICU interventions.20 
This report impresses on the dire need to improve 
NICU facilities and study of prognosis and feasibility 
of NICU intervention in Patau Syndrome.No measures 
were instituted such as genetic counselling and 
screening, which further compounded the 
management in terms of preparedness of the parents.21 
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